AMSTERDAM–(BUSINESS
WIRE)–Tornier N.V., a global medical device company focused on providing
surgical solutions to orthopaedic extremity specialists, today announced it
will highlight a range of products and patient education programs at the
American Academy of Orthopaedic Surgeons 2012 Annual Meeting (“AAOS”) being
held February 8-12 in San Francisco, CA. The highlighted products and education
programs represent each of Torniers extremity categories including upper
Extremity, lower extremity, and sports medicine and biologics.
Doug Kohrs, President and CEO of Tornier, commented, “At
this years AAOS, we are proud to be highlighting products and patient education
programs that evidence Torniers commitment to its orthopaedic specialist
customers and the unmet clinical needs of their patients. We are especially
excited about the five new sports medicine and biologics product introductions
that we believe represent a major step toward Torniers goal to be a market
leader.”
The products and programs to be highlighted at the AAOS
include new products, recently launched or enhanced product lines, and new
patient education programs as follows:
The Aequalis™ Ascend™ Shoulder, launched last year, is
Torniers pioneering minimally invasive shoulder joint replacement system
featuring an innovative stem that has been designed to minimize bone loss and
provide an anatomic fit. The Ascend Shoulder platform is early in its product
cycle with several important market expanding product opportunities already
being evaluated.
The Latitude® II Total Elbow System, in limited release in
the U.S.,
offers procedure simplifying instrumentation and new device sizes to expand the
clinical utility for revisions and fracture surgery. The Latitude Elbow has
been a leader in the elbow joint replacement market based on its ability to
restore the natural kinematics of the elbow.
The RFS™ Cannulated Screw System, in limited release in the U.S., is a new
delivery system for the Companys RFS (Resorbable Fixation System) line for the
repair of fractures and other bone disorders of the foot. The new cannulated
version provides surgeons an option to deploy the RFS screw using a guide wire
for improved precision and simplified delivery. The RFS material technology
features auto-compression that causes the screw to contract in length while
expanding in diameter in hydrolytic conditions, providing sustained compression
during bone healing.
The Insite™ FT Anchor Family, in full release in the U.S., is
Torniers next generation of screw-in suture anchors for the repair of rotator
cuff injuries. The new Insite FT product line features the patented Easy Glide™
independent suture eyelets that reduce suture friction, and a fully threaded
body to enhance bone fixation. The product family includes both titanium and
PEEK anchors, and will complement Torniers innovative Piton™ bone anchor
product line.
The Duo™ Soft Tissue Fixation System, in limited release in
the U.S.,
is worlds first convertible soft-tissue anchor that can be used in either a
tied or knotless fashion for shoulder instability repair, rotator cuff repair,
and other soft tissue applications. The Duo features Torniers patented Cinch™
knotless technology that enables surgeons to adjust the suture tension even
after the insertion device is removed.
The ArthroPass™ Suture Passer, in limited release in the U.S., is a
full-featured suture passer that can be used in nearly every rotator cuff case.
The ArthroPass was developed based on extensive surgeon feedback to provide
ideal ergonomics while providing the necessary features of ratcheting jaws,
efficient tissue grasping, and consistent and reliable suture passing.
The SoloStitch™ Graft Preparation Kit, in limited release in
the U.S.,
is a unique system of templates and tools specifically designed to assist the
surgeon in preparing the Conexa™ Reconstructive Tissue Matrix for arthroscopic
application in rotator cuff surgery. The SoloStitch kit represents the next
evolution of arthroscopic graft placement surgical techniques developed in a
multi-year collaboration with a core team of sports medicine surgeons.
The QuickCell™ Platelet Concentrate System, in limited
release in the U.S.,
is a revolutionary system for preparing concentrated platelets from the
patients own blood. The QuickCell system is fully disposable and eliminates
the need for a centrifuge at the point of care. This new filter-based
technology is designed to be simpler to use, require less processing time, and
yield a higher quality platelet concentrate than traditional centrifuge based
systems.
The LIFT™ and STRIDE™ Patient Education Programs have been
developed by Tornier to increase public awareness of treatment options for
chronic shoulder and ankle pain. The LIFT™ and STRIDE™ programs, for shoulder
and ankle solutions respectively, include a full complement of educational
tools for surgeons to provide their patients. The full range of information is
available at www.liftmyarm.com and www.tornierankle.com. Patients can find information
including the causes of their condition, treatment options, the surgical
procedure, recovery, rehabilitation, and expected outcomes.
About Tornier
Tornier is a global medical device company focused on serving extremities
specialists who treat orthopaedic conditions of the shoulder, elbow, wrist,
hand, ankle and foot. The companys broad offering of approximately 90 product
lines includes joint replacement, trauma, sports medicine, and biologic
products to treat the extremities, as well as joint replacement products for
the hip and knee in certain international markets. Since its founding
approximately 70 years ago, Torniers “Specialists Serving Specialists”
philosophy has fostered a tradition of innovation, intense focus on surgeon
education, and commitment to advancement of orthopaedic technology stemming
from its close collaboration with orthopaedic surgeons and thought leaders
throughout the world. For more information regarding Tornier, visit www.tornier.com.